Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-05-01

AUTHORS

Claire E. Fletcher, Eric Sulpice, Stephanie Combe, Akifumi Shibakawa, Damien A. Leach, Mark P. Hamilton, Stelios L. Chrysostomou, Adam Sharp, Jon Welti, Wei Yuan, Dafydd. A. Dart, Eleanor Knight, Jian Ning, Jeffrey C. Francis, Evangelia E. Kounatidou, Luke Gaughan, Amanda Swain, Shawn E. Lupold, Johann S. de Bono, Sean E. McGuire, Xavier Gidrol, Charlotte L. Bevan

ABSTRACT

Androgen receptor (AR) signalling is a key prostate cancer (PC) driver, even in advanced ‘castrate-resistant’ disease (CRPC). To systematically identify microRNAs (miRs) modulating AR activity in lethal disease, hormone-responsive and -resistant PC cells expressing a luciferase-based AR reporter were transfected with a miR inhibitor library; 78 inhibitors significantly altered AR activity. Upon validation, miR-346, miR-361-3p and miR-197 inhibitors markedly reduced AR transcriptional activity, mRNA and protein levels, increased apoptosis, reduced proliferation, repressed EMT, and inhibited PC migration and invasion, demonstrating additive effects with AR inhibition. Corresponding miRs increased AR activity through a novel and anti-dogmatic mechanism of direct association with AR 6.9 kb 3′UTR and transcript stabilisation. In addition, miR-346 and miR-361-3p modulation altered levels of constitutively active AR variants, and inhibited variant-driven PC cell proliferation, so may contribute to persistent AR signalling in CRPC in the absence of circulating androgens. Pathway analysis of AGO-PAR-CLIP-identified miR targets revealed roles in DNA replication and repair, cell cycle, signal transduction and immune function. Silencing these targets, including tumour suppressors ARHGDIA and TAGLN2, phenocopied miR effects, demonstrating physiological relevance. MiR-346 additionally upregulated the oncogene, YWHAZ, which correlated with grade, biochemical relapse and metastasis in patients. These AR-modulatory miRs and targets correlated with AR activity in patient biopsies, and were elevated in response to long-term enzalutamide treatment of patient-derived CRPC xenografts. In summary, we identified miRs that modulate AR activity in PC and CRPC, via novel mechanisms, and may represent novel PC therapeutic targets. More... »

PAGES

5700-5724

References to SciGraph publications

  • 2011-06-29. In Vitro and In Vivo Silencing of the Androgen Receptor in ANDROGEN ACTION
  • 2015-10-28. miR-346 and miR-138 competitively regulate hTERT in GRSF1- and AGO2-dependent manners, respectively in SCIENTIFIC REPORTS
  • 2007-04-01. Impaired microRNA processing enhances cellular transformation and tumorigenesis in NATURE GENETICS
  • 2013-04-09. miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients in BRITISH JOURNAL OF CANCER
  • 2015-09-02. Distinct EMT programs control normal mammary stem cells and tumour-initiating cells in NATURE
  • 2004-02-16. Androgens target prohibitin to regulate proliferation of prostate cancer cells in ONCOGENE
  • 2013-02-17. MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor in MOLECULAR AND CELLULAR BIOCHEMISTRY
  • 2006-06-05. Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells in ONCOGENE
  • 2006-09-11. Prohibitin, a protein downregulated by androgens, represses androgen receptor activity in ONCOGENE
  • 2009-12-14. MicroRNA function in cancer: oncogene or a tumor suppressor? in CANCER AND METASTASIS REVIEWS
  • 2016-02-29. Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer in NATURE MEDICINE
  • 2010-07-27. The widespread regulation of microRNA biogenesis, function and decay in NATURE REVIEWS GENETICS
  • 2012-03-01. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks in NATURE PROTOCOLS
  • 2007-09-24. Widespread deregulation of microRNA expression in human prostate cancer in ONCOGENE
  • 2011-08-11. TopHat-Fusion: an algorithm for discovery of novel fusion transcripts in GENOME BIOLOGY
  • Journal

    TITLE

    Oncogene

    ISSUE

    28

    VOLUME

    38

    Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/s41388-019-0823-5

    DOI

    http://dx.doi.org/10.1038/s41388-019-0823-5

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1113858655

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/31043708


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "3' Untranslated Regions", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antisense Elements (Genetics)", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Benzamides", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line, Tumor", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Resistance, Neoplasm", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Epithelial-Mesenchymal Transition", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "MicroRNAs", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Invasiveness", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Metastasis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nitriles", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Phenylthiohydantoin", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prostatic Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Receptors, Androgen", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Signal Transduction", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.413629.b", 
              "name": [
                "Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fletcher", 
            "givenName": "Claire E.", 
            "id": "sg:person.01163141777.53", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163141777.53"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Universit\u00e9 Grenoble Alpes, CEA, INSERM, BIG, BGE, 17 Avenue des Martyrs, 38054, Grenoble, France", 
              "id": "http://www.grid.ac/institutes/grid.450307.5", 
              "name": [
                "Universit\u00e9 Grenoble Alpes, CEA, INSERM, BIG, BGE, 17 Avenue des Martyrs, 38054, Grenoble, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sulpice", 
            "givenName": "Eric", 
            "id": "sg:person.01130310301.78", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130310301.78"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Universit\u00e9 Grenoble Alpes, CEA, INSERM, BIG, BGE, 17 Avenue des Martyrs, 38054, Grenoble, France", 
              "id": "http://www.grid.ac/institutes/grid.450307.5", 
              "name": [
                "Universit\u00e9 Grenoble Alpes, CEA, INSERM, BIG, BGE, 17 Avenue des Martyrs, 38054, Grenoble, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Combe", 
            "givenName": "Stephanie", 
            "id": "sg:person.01360765301.50", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360765301.50"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.413629.b", 
              "name": [
                "Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Shibakawa", 
            "givenName": "Akifumi", 
            "id": "sg:person.015203755545.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015203755545.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.413629.b", 
              "name": [
                "Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Leach", 
            "givenName": "Damien A.", 
            "id": "sg:person.0643065664.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643065664.36"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Molecular and Cellular Biology, Baylor College of Medicine, 1 Baylor Plaza Houston M822, 77030, Houston, TX, USA", 
              "id": "http://www.grid.ac/institutes/grid.39382.33", 
              "name": [
                "Department of Molecular and Cellular Biology, Baylor College of Medicine, 1 Baylor Plaza Houston M822, 77030, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hamilton", 
            "givenName": "Mark P.", 
            "id": "sg:person.0626621350.30", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626621350.30"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.413629.b", 
              "name": [
                "Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Chrysostomou", 
            "givenName": "Stelios L.", 
            "id": "sg:person.010202222343.24", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010202222343.24"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Prostate Cancer Target Therapy Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK", 
              "id": "http://www.grid.ac/institutes/grid.5072.0", 
              "name": [
                "Prostate Cancer Target Therapy Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sharp", 
            "givenName": "Adam", 
            "id": "sg:person.012607144475.40", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012607144475.40"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Prostate Cancer Target Therapy Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK", 
              "id": "http://www.grid.ac/institutes/grid.5072.0", 
              "name": [
                "Prostate Cancer Target Therapy Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Welti", 
            "givenName": "Jon", 
            "id": "sg:person.07452037621.65", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07452037621.65"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Prostate Cancer Target Therapy Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK", 
              "id": "http://www.grid.ac/institutes/grid.5072.0", 
              "name": [
                "Prostate Cancer Target Therapy Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yuan", 
            "givenName": "Wei", 
            "id": "sg:person.0721031370.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721031370.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.413629.b", 
              "name": [
                "Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Dart", 
            "givenName": "Dafydd. A.", 
            "id": "sg:person.01231255177.35", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231255177.35"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Tumour Profiling Unit, Institute of Cancer Research, SW3 6JB, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Tumour Profiling Unit, Institute of Cancer Research, SW3 6JB, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Knight", 
            "givenName": "Eleanor", 
            "id": "sg:person.015360666361.34", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015360666361.34"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Tumour Profiling Unit, Institute of Cancer Research, SW3 6JB, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Tumour Profiling Unit, Institute of Cancer Research, SW3 6JB, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ning", 
            "givenName": "Jian", 
            "id": "sg:person.07453175561.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07453175561.46"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Tumour Profiling Unit, Institute of Cancer Research, SW3 6JB, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Tumour Profiling Unit, Institute of Cancer Research, SW3 6JB, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Francis", 
            "givenName": "Jeffrey C.", 
            "id": "sg:person.01261241614.77", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261241614.77"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Northern Institute for Cancer Research, Newcastle University, NE2 4HH, Newcastle upon Tyne, UK", 
              "id": "http://www.grid.ac/institutes/grid.1006.7", 
              "name": [
                "Northern Institute for Cancer Research, Newcastle University, NE2 4HH, Newcastle upon Tyne, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kounatidou", 
            "givenName": "Evangelia E.", 
            "id": "sg:person.014263273126.15", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014263273126.15"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Northern Institute for Cancer Research, Newcastle University, NE2 4HH, Newcastle upon Tyne, UK", 
              "id": "http://www.grid.ac/institutes/grid.1006.7", 
              "name": [
                "Northern Institute for Cancer Research, Newcastle University, NE2 4HH, Newcastle upon Tyne, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gaughan", 
            "givenName": "Luke", 
            "id": "sg:person.01274743262.10", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274743262.10"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Tumour Profiling Unit, Institute of Cancer Research, SW3 6JB, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.18886.3f", 
              "name": [
                "Tumour Profiling Unit, Institute of Cancer Research, SW3 6JB, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Swain", 
            "givenName": "Amanda", 
            "id": "sg:person.01365030230.90", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365030230.90"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA", 
              "id": "http://www.grid.ac/institutes/grid.21107.35", 
              "name": [
                "The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lupold", 
            "givenName": "Shawn E.", 
            "id": "sg:person.0600255467.92", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600255467.92"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Prostate Cancer Target Therapy Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK", 
              "id": "http://www.grid.ac/institutes/grid.5072.0", 
              "name": [
                "Prostate Cancer Target Therapy Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "de Bono", 
            "givenName": "Johann S.", 
            "id": "sg:person.01204004306.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204004306.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA", 
              "id": "http://www.grid.ac/institutes/grid.240145.6", 
              "name": [
                "Department of Molecular and Cell Biology, Baylor College of Medicine Hospital, Houston, TX, USA", 
                "Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA", 
                "Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "McGuire", 
            "givenName": "Sean E.", 
            "id": "sg:person.01137054425.12", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137054425.12"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Universit\u00e9 Grenoble Alpes, CEA, INSERM, BIG, BGE, 17 Avenue des Martyrs, 38054, Grenoble, France", 
              "id": "http://www.grid.ac/institutes/grid.450307.5", 
              "name": [
                "Universit\u00e9 Grenoble Alpes, CEA, INSERM, BIG, BGE, 17 Avenue des Martyrs, 38054, Grenoble, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Gidrol", 
            "givenName": "Xavier", 
            "id": "sg:person.0767110013.03", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767110013.03"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK", 
              "id": "http://www.grid.ac/institutes/grid.413629.b", 
              "name": [
                "Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bevan", 
            "givenName": "Charlotte L.", 
            "id": "sg:person.01046515305.23", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046515305.23"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nature14897", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025946880", 
              "https://doi.org/10.1038/nature14897"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/srep15793", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053194050", 
              "https://doi.org/10.1038/srep15793"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11010-013-1576-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002776069", 
              "https://doi.org/10.1007/s11010-013-1576-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nm.4053", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043166959", 
              "https://doi.org/10.1038/nm.4053"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrg2843", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028796698", 
              "https://doi.org/10.1038/nrg2843"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1209715", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028811468", 
              "https://doi.org/10.1038/sj.onc.1209715"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/gb-2011-12-8-r72", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006381787", 
              "https://doi.org/10.1186/gb-2011-12-8-r72"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1209967", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005493321", 
              "https://doi.org/10.1038/sj.onc.1209967"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ng2003", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036221931", 
              "https://doi.org/10.1038/ng2003"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s10555-009-9188-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001631032", 
              "https://doi.org/10.1007/s10555-009-9188-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-61779-243-4_7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025965676", 
              "https://doi.org/10.1007/978-1-61779-243-4_7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1207444", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008448139", 
              "https://doi.org/10.1038/sj.onc.1207444"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nprot.2012.016", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1030124536", 
              "https://doi.org/10.1038/nprot.2012.016"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.2013.131", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003733575", 
              "https://doi.org/10.1038/bjc.2013.131"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1210809", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021715986", 
              "https://doi.org/10.1038/sj.onc.1210809"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2019-05-01", 
        "datePublishedReg": "2019-05-01", 
        "description": "Androgen receptor (AR) signalling is a key prostate cancer (PC) driver, even in advanced \u2018castrate-resistant\u2019 disease (CRPC). To systematically identify microRNAs (miRs) modulating AR activity in lethal disease, hormone-responsive and -resistant PC cells expressing a luciferase-based AR reporter were transfected with a miR inhibitor library; 78 inhibitors significantly altered AR activity. Upon validation, miR-346, miR-361-3p and miR-197 inhibitors markedly reduced AR transcriptional activity, mRNA and protein levels, increased apoptosis, reduced proliferation, repressed EMT, and inhibited PC migration and invasion, demonstrating additive effects with AR inhibition. Corresponding miRs increased AR activity through a novel and anti-dogmatic mechanism of direct association with AR 6.9\u2009kb 3\u2032UTR and transcript stabilisation. In addition, miR-346 and miR-361-3p modulation altered levels of constitutively active AR variants, and inhibited variant-driven PC cell proliferation, so may contribute to persistent AR signalling in CRPC in the absence of circulating androgens. Pathway analysis of AGO-PAR-CLIP-identified miR targets revealed roles in DNA replication and repair, cell cycle, signal transduction and immune function. Silencing these targets, including tumour suppressors ARHGDIA and TAGLN2, phenocopied miR effects, demonstrating physiological relevance. MiR-346 additionally upregulated the oncogene, YWHAZ, which correlated with grade, biochemical relapse and metastasis in patients. These AR-modulatory miRs and targets correlated with AR activity in patient biopsies, and were elevated in response to long-term enzalutamide treatment of patient-derived CRPC xenografts. In summary, we identified miRs that modulate AR activity in PC and CRPC, via novel mechanisms, and may represent novel PC therapeutic targets.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/s41388-019-0823-5", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.5071566", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.9250310", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.4316556", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1097543", 
            "issn": [
              "0950-9232", 
              "1476-5594"
            ], 
            "name": "Oncogene", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "28", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "38"
          }
        ], 
        "keywords": [
          "AR activity", 
          "miR-346", 
          "therapeutic target", 
          "advanced prostate cancer", 
          "androgen receptor signaling", 
          "AR transcriptional activity", 
          "PC cell proliferation", 
          "active AR variants", 
          "miR-197 inhibitor", 
          "persistent AR", 
          "CRPC xenografts", 
          "enzalutamide treatment", 
          "biochemical relapse", 
          "prostate cancer", 
          "PC cells", 
          "AR variants", 
          "AR inhibition", 
          "immune function", 
          "patient biopsies", 
          "therapy resistance", 
          "PC migration", 
          "lethal disease", 
          "receptor signaling", 
          "reduced proliferation", 
          "protein levels", 
          "cell proliferation", 
          "CRPC", 
          "disease", 
          "additive effect", 
          "pathway analysis", 
          "miR", 
          "direct association", 
          "novel mechanism", 
          "physiological relevance", 
          "miR targets", 
          "cell cycle", 
          "transcriptional activity", 
          "inhibitors", 
          "proliferation", 
          "inhibitor library", 
          "miR effects", 
          "target", 
          "microRNAs", 
          "relapse", 
          "patients", 
          "biopsy", 
          "metastasis", 
          "cancer drivers", 
          "androgens", 
          "xenografts", 
          "activity", 
          "cancer", 
          "EMT", 
          "signal transduction", 
          "levels", 
          "treatment", 
          "apoptosis", 
          "invasion", 
          "TAGLN2", 
          "inhibition", 
          "association", 
          "repair", 
          "oncogene", 
          "signaling", 
          "mRNA", 
          "effect", 
          "cells", 
          "grade", 
          "ARHGDIA", 
          "YWHAZ", 
          "mechanism", 
          "response", 
          "reporter", 
          "modulation", 
          "absence", 
          "replication", 
          "variants", 
          "summary", 
          "role", 
          "clips", 
          "transduction", 
          "relevance", 
          "DNA replication", 
          "resistance", 
          "migration", 
          "function", 
          "addition", 
          "stabilisation", 
          "analysis", 
          "validation", 
          "cycle", 
          "library", 
          "insights", 
          "Ar", 
          "PC", 
          "drivers"
        ], 
        "name": "Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer", 
        "pagination": "5700-5724", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1113858655"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/s41388-019-0823-5"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "31043708"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/s41388-019-0823-5", 
          "https://app.dimensions.ai/details/publication/pub.1113858655"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-05-20T07:36", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_826.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/s41388-019-0823-5"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/s41388-019-0823-5'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/s41388-019-0823-5'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/s41388-019-0823-5'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/s41388-019-0823-5'


     

    This table displays all metadata directly associated to this object as RDF triples.

    458 TRIPLES      22 PREDICATES      153 URIs      130 LITERALS      23 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/s41388-019-0823-5 schema:about N03bcbd0ab1184d8b90ded97f45526683
    2 N2a601291bd194c6a8b2a487932147683
    3 N30e3fdf5c8b541a99bdbe5e2d1c1164b
    4 N3ddde0e0a61741238f343e620b751c8b
    5 N5a266d159f98465ea2bcb84a665e01a7
    6 N6e08c392c96d4eaf947278e99d63f813
    7 N97b6eba1c7eb4f1ab0c7a508ca67d088
    8 Na0cc99e03a0348c9876db16a63cc98cc
    9 Na1afc0ac427b4ae6b2ee273ae9741dc3
    10 Na8dff9c4b82d4cf28a567c7d51a0c7d9
    11 Nb2e32eb08dcf4c39a906d1f146f636a6
    12 Nb53335e4100643d1a71c44bdc6c94dc7
    13 Nbf0be82f75ed48e6babbfdb8f2822187
    14 Nf33c66bcd42b4582bdab115e858ed9b8
    15 Nf35843ecf47e4e51b50f0ef2ce01bb1a
    16 Nfe94343a9332478daf441fc7e78ad0ba
    17 anzsrc-for:11
    18 anzsrc-for:1112
    19 schema:author N9a29e9dec9b941c5866fb1f1336759aa
    20 schema:citation sg:pub.10.1007/978-1-61779-243-4_7
    21 sg:pub.10.1007/s10555-009-9188-5
    22 sg:pub.10.1007/s11010-013-1576-z
    23 sg:pub.10.1038/bjc.2013.131
    24 sg:pub.10.1038/nature14897
    25 sg:pub.10.1038/ng2003
    26 sg:pub.10.1038/nm.4053
    27 sg:pub.10.1038/nprot.2012.016
    28 sg:pub.10.1038/nrg2843
    29 sg:pub.10.1038/sj.onc.1207444
    30 sg:pub.10.1038/sj.onc.1209715
    31 sg:pub.10.1038/sj.onc.1209967
    32 sg:pub.10.1038/sj.onc.1210809
    33 sg:pub.10.1038/srep15793
    34 sg:pub.10.1186/gb-2011-12-8-r72
    35 schema:datePublished 2019-05-01
    36 schema:datePublishedReg 2019-05-01
    37 schema:description Androgen receptor (AR) signalling is a key prostate cancer (PC) driver, even in advanced ‘castrate-resistant’ disease (CRPC). To systematically identify microRNAs (miRs) modulating AR activity in lethal disease, hormone-responsive and -resistant PC cells expressing a luciferase-based AR reporter were transfected with a miR inhibitor library; 78 inhibitors significantly altered AR activity. Upon validation, miR-346, miR-361-3p and miR-197 inhibitors markedly reduced AR transcriptional activity, mRNA and protein levels, increased apoptosis, reduced proliferation, repressed EMT, and inhibited PC migration and invasion, demonstrating additive effects with AR inhibition. Corresponding miRs increased AR activity through a novel and anti-dogmatic mechanism of direct association with AR 6.9 kb 3′UTR and transcript stabilisation. In addition, miR-346 and miR-361-3p modulation altered levels of constitutively active AR variants, and inhibited variant-driven PC cell proliferation, so may contribute to persistent AR signalling in CRPC in the absence of circulating androgens. Pathway analysis of AGO-PAR-CLIP-identified miR targets revealed roles in DNA replication and repair, cell cycle, signal transduction and immune function. Silencing these targets, including tumour suppressors ARHGDIA and TAGLN2, phenocopied miR effects, demonstrating physiological relevance. MiR-346 additionally upregulated the oncogene, YWHAZ, which correlated with grade, biochemical relapse and metastasis in patients. These AR-modulatory miRs and targets correlated with AR activity in patient biopsies, and were elevated in response to long-term enzalutamide treatment of patient-derived CRPC xenografts. In summary, we identified miRs that modulate AR activity in PC and CRPC, via novel mechanisms, and may represent novel PC therapeutic targets.
    38 schema:genre article
    39 schema:inLanguage en
    40 schema:isAccessibleForFree true
    41 schema:isPartOf Nd867125d30d14a939a0dfb14fc27cd8a
    42 Ne55932c3586f471bb85a21a6f7a8ceef
    43 sg:journal.1097543
    44 schema:keywords AR activity
    45 AR inhibition
    46 AR transcriptional activity
    47 AR variants
    48 ARHGDIA
    49 Ar
    50 CRPC
    51 CRPC xenografts
    52 DNA replication
    53 EMT
    54 PC
    55 PC cell proliferation
    56 PC cells
    57 PC migration
    58 TAGLN2
    59 YWHAZ
    60 absence
    61 active AR variants
    62 activity
    63 addition
    64 additive effect
    65 advanced prostate cancer
    66 analysis
    67 androgen receptor signaling
    68 androgens
    69 apoptosis
    70 association
    71 biochemical relapse
    72 biopsy
    73 cancer
    74 cancer drivers
    75 cell cycle
    76 cell proliferation
    77 cells
    78 clips
    79 cycle
    80 direct association
    81 disease
    82 drivers
    83 effect
    84 enzalutamide treatment
    85 function
    86 grade
    87 immune function
    88 inhibition
    89 inhibitor library
    90 inhibitors
    91 insights
    92 invasion
    93 lethal disease
    94 levels
    95 library
    96 mRNA
    97 mechanism
    98 metastasis
    99 miR
    100 miR effects
    101 miR targets
    102 miR-197 inhibitor
    103 miR-346
    104 microRNAs
    105 migration
    106 modulation
    107 novel mechanism
    108 oncogene
    109 pathway analysis
    110 patient biopsies
    111 patients
    112 persistent AR
    113 physiological relevance
    114 proliferation
    115 prostate cancer
    116 protein levels
    117 receptor signaling
    118 reduced proliferation
    119 relapse
    120 relevance
    121 repair
    122 replication
    123 reporter
    124 resistance
    125 response
    126 role
    127 signal transduction
    128 signaling
    129 stabilisation
    130 summary
    131 target
    132 therapeutic target
    133 therapy resistance
    134 transcriptional activity
    135 transduction
    136 treatment
    137 validation
    138 variants
    139 xenografts
    140 schema:name Androgen receptor-modulatory microRNAs provide insight into therapy resistance and therapeutic targets in advanced prostate cancer
    141 schema:pagination 5700-5724
    142 schema:productId N1d7d694a286f4aa59cdca748dcbbcc1f
    143 N49099dd402bc4418833b1d45562db236
    144 N771a16f9ff4246a098d3dfde9d8fc928
    145 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113858655
    146 https://doi.org/10.1038/s41388-019-0823-5
    147 schema:sdDatePublished 2022-05-20T07:36
    148 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    149 schema:sdPublisher N7bb9aa9744cc4981879fe358a37ab874
    150 schema:url https://doi.org/10.1038/s41388-019-0823-5
    151 sgo:license sg:explorer/license/
    152 sgo:sdDataset articles
    153 rdf:type schema:ScholarlyArticle
    154 N02fa523d62a649e68bbafeade3485e15 rdf:first sg:person.0767110013.03
    155 rdf:rest Nba67d48510a04f2b98ce3e57b6198089
    156 N03bcbd0ab1184d8b90ded97f45526683 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Signal Transduction
    158 rdf:type schema:DefinedTerm
    159 N1d7d694a286f4aa59cdca748dcbbcc1f schema:name doi
    160 schema:value 10.1038/s41388-019-0823-5
    161 rdf:type schema:PropertyValue
    162 N2a601291bd194c6a8b2a487932147683 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Phenylthiohydantoin
    164 rdf:type schema:DefinedTerm
    165 N30e3fdf5c8b541a99bdbe5e2d1c1164b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Antisense Elements (Genetics)
    167 rdf:type schema:DefinedTerm
    168 N315074046ee54f9bb648b821cb3be6b0 rdf:first sg:person.01231255177.35
    169 rdf:rest Ne2dec67615e8432aa990fe33a9dbdd5b
    170 N3ddde0e0a61741238f343e620b751c8b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    171 schema:name Receptors, Androgen
    172 rdf:type schema:DefinedTerm
    173 N49099dd402bc4418833b1d45562db236 schema:name dimensions_id
    174 schema:value pub.1113858655
    175 rdf:type schema:PropertyValue
    176 N51875af99a054fa2b2c3c642fc52c27d rdf:first sg:person.014263273126.15
    177 rdf:rest Nfed78372ee0b44a7a43b627e2dea9b2a
    178 N5246e04fb0a8412d90c239b893f12fba rdf:first sg:person.012607144475.40
    179 rdf:rest N6f4bd2b119f849c0a59999b275731c97
    180 N5a266d159f98465ea2bcb84a665e01a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    181 schema:name Cell Line, Tumor
    182 rdf:type schema:DefinedTerm
    183 N5ec3d246674e45858606edd4f68b8703 rdf:first sg:person.01130310301.78
    184 rdf:rest Nf3975d5f953240b59a918768408b4ddc
    185 N61b4d668e7f54cb4b008827a111bd1ba rdf:first sg:person.010202222343.24
    186 rdf:rest N5246e04fb0a8412d90c239b893f12fba
    187 N6aa53ded6c1540228d04e72eb09c3671 rdf:first sg:person.07453175561.46
    188 rdf:rest Nd745914930034a42900d66c61b440f30
    189 N6e08c392c96d4eaf947278e99d63f813 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name Drug Resistance, Neoplasm
    191 rdf:type schema:DefinedTerm
    192 N6f4bd2b119f849c0a59999b275731c97 rdf:first sg:person.07452037621.65
    193 rdf:rest N8e18356cf8234f4896d9c3f2c570675a
    194 N70c977e10c4a40079ba1b7e1c1a4f7c9 rdf:first sg:person.015203755545.22
    195 rdf:rest Na54a8527811c47f48b8aa99cb1f5e7d4
    196 N771a16f9ff4246a098d3dfde9d8fc928 schema:name pubmed_id
    197 schema:value 31043708
    198 rdf:type schema:PropertyValue
    199 N7a647091b81841dba280e89034cfd618 rdf:first sg:person.0600255467.92
    200 rdf:rest Naa803275c6274068b1e71a9a9c4e4657
    201 N7bb9aa9744cc4981879fe358a37ab874 schema:name Springer Nature - SN SciGraph project
    202 rdf:type schema:Organization
    203 N7eb94a8b6a6d4894a957f2418348e2b5 rdf:first sg:person.01365030230.90
    204 rdf:rest N7a647091b81841dba280e89034cfd618
    205 N8e18356cf8234f4896d9c3f2c570675a rdf:first sg:person.0721031370.17
    206 rdf:rest N315074046ee54f9bb648b821cb3be6b0
    207 N9024e34d20294a20926c510dc69f9d01 rdf:first sg:person.0626621350.30
    208 rdf:rest N61b4d668e7f54cb4b008827a111bd1ba
    209 N97b6eba1c7eb4f1ab0c7a508ca67d088 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    210 schema:name Epithelial-Mesenchymal Transition
    211 rdf:type schema:DefinedTerm
    212 N9a29e9dec9b941c5866fb1f1336759aa rdf:first sg:person.01163141777.53
    213 rdf:rest N5ec3d246674e45858606edd4f68b8703
    214 Na0cc99e03a0348c9876db16a63cc98cc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    215 schema:name Male
    216 rdf:type schema:DefinedTerm
    217 Na1afc0ac427b4ae6b2ee273ae9741dc3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    218 schema:name Neoplasm Metastasis
    219 rdf:type schema:DefinedTerm
    220 Na54a8527811c47f48b8aa99cb1f5e7d4 rdf:first sg:person.0643065664.36
    221 rdf:rest N9024e34d20294a20926c510dc69f9d01
    222 Na8dff9c4b82d4cf28a567c7d51a0c7d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    223 schema:name Benzamides
    224 rdf:type schema:DefinedTerm
    225 Naa803275c6274068b1e71a9a9c4e4657 rdf:first sg:person.01204004306.08
    226 rdf:rest Naecbe5d1d7804e3a982d5f719b907cc5
    227 Naecbe5d1d7804e3a982d5f719b907cc5 rdf:first sg:person.01137054425.12
    228 rdf:rest N02fa523d62a649e68bbafeade3485e15
    229 Nb2e32eb08dcf4c39a906d1f146f636a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    230 schema:name 3' Untranslated Regions
    231 rdf:type schema:DefinedTerm
    232 Nb53335e4100643d1a71c44bdc6c94dc7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    233 schema:name Neoplasm Invasiveness
    234 rdf:type schema:DefinedTerm
    235 Nba67d48510a04f2b98ce3e57b6198089 rdf:first sg:person.01046515305.23
    236 rdf:rest rdf:nil
    237 Nbf0be82f75ed48e6babbfdb8f2822187 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    238 schema:name Nitriles
    239 rdf:type schema:DefinedTerm
    240 Nd745914930034a42900d66c61b440f30 rdf:first sg:person.01261241614.77
    241 rdf:rest N51875af99a054fa2b2c3c642fc52c27d
    242 Nd867125d30d14a939a0dfb14fc27cd8a schema:issueNumber 28
    243 rdf:type schema:PublicationIssue
    244 Ne2dec67615e8432aa990fe33a9dbdd5b rdf:first sg:person.015360666361.34
    245 rdf:rest N6aa53ded6c1540228d04e72eb09c3671
    246 Ne55932c3586f471bb85a21a6f7a8ceef schema:volumeNumber 38
    247 rdf:type schema:PublicationVolume
    248 Nf33c66bcd42b4582bdab115e858ed9b8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    249 schema:name MicroRNAs
    250 rdf:type schema:DefinedTerm
    251 Nf35843ecf47e4e51b50f0ef2ce01bb1a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    252 schema:name Prostatic Neoplasms
    253 rdf:type schema:DefinedTerm
    254 Nf3975d5f953240b59a918768408b4ddc rdf:first sg:person.01360765301.50
    255 rdf:rest N70c977e10c4a40079ba1b7e1c1a4f7c9
    256 Nfe94343a9332478daf441fc7e78ad0ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    257 schema:name Humans
    258 rdf:type schema:DefinedTerm
    259 Nfed78372ee0b44a7a43b627e2dea9b2a rdf:first sg:person.01274743262.10
    260 rdf:rest N7eb94a8b6a6d4894a957f2418348e2b5
    261 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    262 schema:name Medical and Health Sciences
    263 rdf:type schema:DefinedTerm
    264 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    265 schema:name Oncology and Carcinogenesis
    266 rdf:type schema:DefinedTerm
    267 sg:grant.4316556 http://pending.schema.org/fundedItem sg:pub.10.1038/s41388-019-0823-5
    268 rdf:type schema:MonetaryGrant
    269 sg:grant.5071566 http://pending.schema.org/fundedItem sg:pub.10.1038/s41388-019-0823-5
    270 rdf:type schema:MonetaryGrant
    271 sg:grant.9250310 http://pending.schema.org/fundedItem sg:pub.10.1038/s41388-019-0823-5
    272 rdf:type schema:MonetaryGrant
    273 sg:journal.1097543 schema:issn 0950-9232
    274 1476-5594
    275 schema:name Oncogene
    276 schema:publisher Springer Nature
    277 rdf:type schema:Periodical
    278 sg:person.010202222343.24 schema:affiliation grid-institutes:grid.413629.b
    279 schema:familyName Chrysostomou
    280 schema:givenName Stelios L.
    281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010202222343.24
    282 rdf:type schema:Person
    283 sg:person.01046515305.23 schema:affiliation grid-institutes:grid.413629.b
    284 schema:familyName Bevan
    285 schema:givenName Charlotte L.
    286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01046515305.23
    287 rdf:type schema:Person
    288 sg:person.01130310301.78 schema:affiliation grid-institutes:grid.450307.5
    289 schema:familyName Sulpice
    290 schema:givenName Eric
    291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01130310301.78
    292 rdf:type schema:Person
    293 sg:person.01137054425.12 schema:affiliation grid-institutes:grid.240145.6
    294 schema:familyName McGuire
    295 schema:givenName Sean E.
    296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137054425.12
    297 rdf:type schema:Person
    298 sg:person.01163141777.53 schema:affiliation grid-institutes:grid.413629.b
    299 schema:familyName Fletcher
    300 schema:givenName Claire E.
    301 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163141777.53
    302 rdf:type schema:Person
    303 sg:person.01204004306.08 schema:affiliation grid-institutes:grid.5072.0
    304 schema:familyName de Bono
    305 schema:givenName Johann S.
    306 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204004306.08
    307 rdf:type schema:Person
    308 sg:person.01231255177.35 schema:affiliation grid-institutes:grid.413629.b
    309 schema:familyName Dart
    310 schema:givenName Dafydd. A.
    311 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01231255177.35
    312 rdf:type schema:Person
    313 sg:person.012607144475.40 schema:affiliation grid-institutes:grid.5072.0
    314 schema:familyName Sharp
    315 schema:givenName Adam
    316 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012607144475.40
    317 rdf:type schema:Person
    318 sg:person.01261241614.77 schema:affiliation grid-institutes:grid.18886.3f
    319 schema:familyName Francis
    320 schema:givenName Jeffrey C.
    321 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261241614.77
    322 rdf:type schema:Person
    323 sg:person.01274743262.10 schema:affiliation grid-institutes:grid.1006.7
    324 schema:familyName Gaughan
    325 schema:givenName Luke
    326 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01274743262.10
    327 rdf:type schema:Person
    328 sg:person.01360765301.50 schema:affiliation grid-institutes:grid.450307.5
    329 schema:familyName Combe
    330 schema:givenName Stephanie
    331 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360765301.50
    332 rdf:type schema:Person
    333 sg:person.01365030230.90 schema:affiliation grid-institutes:grid.18886.3f
    334 schema:familyName Swain
    335 schema:givenName Amanda
    336 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01365030230.90
    337 rdf:type schema:Person
    338 sg:person.014263273126.15 schema:affiliation grid-institutes:grid.1006.7
    339 schema:familyName Kounatidou
    340 schema:givenName Evangelia E.
    341 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014263273126.15
    342 rdf:type schema:Person
    343 sg:person.015203755545.22 schema:affiliation grid-institutes:grid.413629.b
    344 schema:familyName Shibakawa
    345 schema:givenName Akifumi
    346 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015203755545.22
    347 rdf:type schema:Person
    348 sg:person.015360666361.34 schema:affiliation grid-institutes:grid.18886.3f
    349 schema:familyName Knight
    350 schema:givenName Eleanor
    351 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015360666361.34
    352 rdf:type schema:Person
    353 sg:person.0600255467.92 schema:affiliation grid-institutes:grid.21107.35
    354 schema:familyName Lupold
    355 schema:givenName Shawn E.
    356 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600255467.92
    357 rdf:type schema:Person
    358 sg:person.0626621350.30 schema:affiliation grid-institutes:grid.39382.33
    359 schema:familyName Hamilton
    360 schema:givenName Mark P.
    361 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626621350.30
    362 rdf:type schema:Person
    363 sg:person.0643065664.36 schema:affiliation grid-institutes:grid.413629.b
    364 schema:familyName Leach
    365 schema:givenName Damien A.
    366 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0643065664.36
    367 rdf:type schema:Person
    368 sg:person.0721031370.17 schema:affiliation grid-institutes:grid.5072.0
    369 schema:familyName Yuan
    370 schema:givenName Wei
    371 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721031370.17
    372 rdf:type schema:Person
    373 sg:person.07452037621.65 schema:affiliation grid-institutes:grid.5072.0
    374 schema:familyName Welti
    375 schema:givenName Jon
    376 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07452037621.65
    377 rdf:type schema:Person
    378 sg:person.07453175561.46 schema:affiliation grid-institutes:grid.18886.3f
    379 schema:familyName Ning
    380 schema:givenName Jian
    381 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07453175561.46
    382 rdf:type schema:Person
    383 sg:person.0767110013.03 schema:affiliation grid-institutes:grid.450307.5
    384 schema:familyName Gidrol
    385 schema:givenName Xavier
    386 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767110013.03
    387 rdf:type schema:Person
    388 sg:pub.10.1007/978-1-61779-243-4_7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025965676
    389 https://doi.org/10.1007/978-1-61779-243-4_7
    390 rdf:type schema:CreativeWork
    391 sg:pub.10.1007/s10555-009-9188-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001631032
    392 https://doi.org/10.1007/s10555-009-9188-5
    393 rdf:type schema:CreativeWork
    394 sg:pub.10.1007/s11010-013-1576-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1002776069
    395 https://doi.org/10.1007/s11010-013-1576-z
    396 rdf:type schema:CreativeWork
    397 sg:pub.10.1038/bjc.2013.131 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003733575
    398 https://doi.org/10.1038/bjc.2013.131
    399 rdf:type schema:CreativeWork
    400 sg:pub.10.1038/nature14897 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025946880
    401 https://doi.org/10.1038/nature14897
    402 rdf:type schema:CreativeWork
    403 sg:pub.10.1038/ng2003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036221931
    404 https://doi.org/10.1038/ng2003
    405 rdf:type schema:CreativeWork
    406 sg:pub.10.1038/nm.4053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043166959
    407 https://doi.org/10.1038/nm.4053
    408 rdf:type schema:CreativeWork
    409 sg:pub.10.1038/nprot.2012.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030124536
    410 https://doi.org/10.1038/nprot.2012.016
    411 rdf:type schema:CreativeWork
    412 sg:pub.10.1038/nrg2843 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028796698
    413 https://doi.org/10.1038/nrg2843
    414 rdf:type schema:CreativeWork
    415 sg:pub.10.1038/sj.onc.1207444 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008448139
    416 https://doi.org/10.1038/sj.onc.1207444
    417 rdf:type schema:CreativeWork
    418 sg:pub.10.1038/sj.onc.1209715 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028811468
    419 https://doi.org/10.1038/sj.onc.1209715
    420 rdf:type schema:CreativeWork
    421 sg:pub.10.1038/sj.onc.1209967 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005493321
    422 https://doi.org/10.1038/sj.onc.1209967
    423 rdf:type schema:CreativeWork
    424 sg:pub.10.1038/sj.onc.1210809 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021715986
    425 https://doi.org/10.1038/sj.onc.1210809
    426 rdf:type schema:CreativeWork
    427 sg:pub.10.1038/srep15793 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053194050
    428 https://doi.org/10.1038/srep15793
    429 rdf:type schema:CreativeWork
    430 sg:pub.10.1186/gb-2011-12-8-r72 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006381787
    431 https://doi.org/10.1186/gb-2011-12-8-r72
    432 rdf:type schema:CreativeWork
    433 grid-institutes:grid.1006.7 schema:alternateName Northern Institute for Cancer Research, Newcastle University, NE2 4HH, Newcastle upon Tyne, UK
    434 schema:name Northern Institute for Cancer Research, Newcastle University, NE2 4HH, Newcastle upon Tyne, UK
    435 rdf:type schema:Organization
    436 grid-institutes:grid.18886.3f schema:alternateName Tumour Profiling Unit, Institute of Cancer Research, SW3 6JB, London, UK
    437 schema:name Tumour Profiling Unit, Institute of Cancer Research, SW3 6JB, London, UK
    438 rdf:type schema:Organization
    439 grid-institutes:grid.21107.35 schema:alternateName The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    440 schema:name The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    441 rdf:type schema:Organization
    442 grid-institutes:grid.240145.6 schema:alternateName Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    443 schema:name Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA
    444 Department of Molecular and Cell Biology, Baylor College of Medicine Hospital, Houston, TX, USA
    445 Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    446 rdf:type schema:Organization
    447 grid-institutes:grid.39382.33 schema:alternateName Department of Molecular and Cellular Biology, Baylor College of Medicine, 1 Baylor Plaza Houston M822, 77030, Houston, TX, USA
    448 schema:name Department of Molecular and Cellular Biology, Baylor College of Medicine, 1 Baylor Plaza Houston M822, 77030, Houston, TX, USA
    449 rdf:type schema:Organization
    450 grid-institutes:grid.413629.b schema:alternateName Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK
    451 schema:name Imperial Centre for Translational and Experimental Medicine, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital, Du Cane Road, W12 0NN, London, UK
    452 rdf:type schema:Organization
    453 grid-institutes:grid.450307.5 schema:alternateName Université Grenoble Alpes, CEA, INSERM, BIG, BGE, 17 Avenue des Martyrs, 38054, Grenoble, France
    454 schema:name Université Grenoble Alpes, CEA, INSERM, BIG, BGE, 17 Avenue des Martyrs, 38054, Grenoble, France
    455 rdf:type schema:Organization
    456 grid-institutes:grid.5072.0 schema:alternateName Prostate Cancer Target Therapy Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK
    457 schema:name Prostate Cancer Target Therapy Group, Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, UK
    458 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...